APOC3 and type 1 diabetes mellitus: In mouse models of type 1 diabetes‐accelerated atherosclerosis, relative insulin deficiency rather than hyperglycemia elevated levels of APOC3, and antisense oligonucleotide of APOC3 treatment abolished the increased hepatic APOC3 expression and lowered TRLs in diabetic mice without improving glycemic control.59